首页> 外文期刊>European neurology >Local Muscle Injection of Botulinum Toxin Type A Synergistically Improves the Beneficial Effects of Repetitive Transcranial Magnetic Stimulation and Intensive Occupational Therapy in Post-Stroke Patients with Spastic Upper Limb Hemiparesis
【24h】

Local Muscle Injection of Botulinum Toxin Type A Synergistically Improves the Beneficial Effects of Repetitive Transcranial Magnetic Stimulation and Intensive Occupational Therapy in Post-Stroke Patients with Spastic Upper Limb Hemiparesis

机译:局部肌肉注射A型肉毒杆菌毒素可协同改善卒中后痉挛性上肢偏瘫的重复经颅磁刺激和强化治疗的有益作用

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The purpose of this study was to determine whether local injection of botulinum toxin type A (BoNT-A) into the spastic muscles has any added benefits to repetitive transcranial magnetic stimulation (RTMS)/occupational therapy (OT) in patients with spastic upper limb hemiparesis. Methods: The study subjects of 80 post-stroke patients with spastic upper limb hemiparesis (age: 60.2 +/- 13.0 years, time after stroke: 55.3 +/- 43.0 months), were divided into the BoNT-A plus RTMS/OT group and RTMS/OT group. BoNT-A was injected into the spastic muscles (total dose: 240 units) before RTMS/OT. The latter included 12 sessions of 40 min RTMS over the non-lesional hemisphere and 240-min intensive OT daily over 15 days. Spasticity was evaluated by the modified Ashworth scale (MAS) and the motor function of the affected upper limb was evaluated serially with Fugl-Meyer Assessment and Wolf Motor Function Tests. Results: Both groups showed significant improvements in spasticity and motor function. The addition of BoNT-A resulted in better improvement in FMA score and MAS of finger flexor muscles (p < 0.05). Conclusions: The triple-element protocol of local injection of BoNT-A into spastic finger muscles, RTMS and intensive OT, is a promising therapeutic program for post-stroke spastic upper limb hemiparesis, although its significance should be confirmed in randomized, placebo-controlled trials. (C) 2014 S. Karger AG, Basel
机译:背景:本研究的目的是确定痉挛性上肢患者经局部肌肉注射A型肉毒毒素(BoNT-A)是否对重复经颅磁刺激(RTMS)/职业疗法(OT)有任何额外的好处肢体偏瘫。方法:将80例卒中后痉挛性上肢偏瘫患者(年龄:60.2 +/- 13.0岁,卒中后时间:55.3 +/- 43.0个月)分为BoNT-A加RTMS / OT组和RTMS / OT组。在RTMS / OT之前,将BoNT-A注射到痉挛性肌肉中(总剂量:240单位)。后者包括在非病变半球上进行12次40分钟的RTMS,并在15天内每天进行240分钟的强化OT。通过改良的Ashworth量表(MAS)评估痉挛,并通过Fugl-Meyer评估和Wolf运动功能测试连续评估患上肢的运动功能。结果:两组均显示出痉挛和运动功能的显着改善。 BoNT-A的添加可改善手指屈肌的FMA评分和MAS(p <0.05)。结论:将BoNT-A局部注射到痉挛性手指肌肉,RTMS和密集性OT中的三元素方案是中风后痉挛性上肢偏瘫的有前途的治疗方案,尽管其意义应在随机,安慰剂对照下证实审判。 (C)2014 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号